We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
+9.61%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$149M
AUM Growth
-$27.3M
(-16%)
Cap. Flow
-$34.7M
Cap. Flow
% of AUM
-23.28%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
298
New
63
Increased
40
Reduced
80
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABVX
Abivax
ABVX
|
+$2.73M |
| 2 |
Pfizer
PFE
|
+$2.42M |
| 3 |
argenx
ARGX
|
+$2.33M |
| 4 |
VYNE Therapeutics
VYNE
|
+$2.08M |
| 5 |
Invesco NASDAQ 100 ETF
QQQM
|
+$1.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neurocrine Biosciences
NBIX
|
+$3.38M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$2.95M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$2.75M |
| 4 |
TSVT
2seventy bio
TSVT
|
+$2.58M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
+$2.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.47% |
| 2 | Real Estate | 11.94% |
| 3 | Financials | 4.93% |
| 4 | Consumer Discretionary | 2.41% |
| 5 | Industrials | 2.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares MSCI United Kingdom ETF
EWU
$3.97B
| $113K | 0.08% |
3,416
-501
| -13% | -$16K |
|
152
Cigna
CI
$75.1B
| $112K | 0.08% |
373
-1,146
| -75% | -$335K |
|
153
Celanese
CE
$4.89B
| $111K | 0.07% |
+717
| New | +$93.5K |
|
154
iShares MSCI Spain ETF
EWP
$1.95B
| $111K | 0.07% |
3,625
-777
| -18% | -$22.4K |
|
155
Synchrony
SYF
$24.7B
| $110K | 0.07% |
+2,871
| New | +$90.8K |
|
156
Wells Fargo
WFC
$261B
| $108K | 0.07% |
+2,198
| New | +$94.9K |
|
157
McKesson
MCK
$97.3B
| $108K | 0.07% |
233
-680
| -74% | -$309K |
|
158
Charter Communications
CHTR
$15.9B
| $107K | 0.07% |
+276
| New | +$113K |
|
159
Jabil
JBL
$32.1B
| $106K | 0.07% |
835
-83
| -9% | -$10.6K |
|
160
Comcast
CMCSA
$84.9B
| $106K | 0.07% |
+2,407
| New | +$103K |
|
161
General Motors
GM
$68.3B
| $103K | 0.07% |
2,872
-339
| -11% | -$10.5K |
|
162
Apollo Global Management
APO
$68.2B
| $103K | 0.07% |
1,103
-104
| -9% | -$9.18K |
|
163
Assurant
AIZ
$13.6B
| $102K | 0.07% |
+604
| New | +$96K |
|
164
DaVita
DVA
$15B
| $98.7K | 0.07% |
+942
| New | +$87K |
|
165
EQT Corp
EQT
$30.7B
| $98K | 0.07% |
2,535
-5,785
| -70% | -$235K |
|
|
ASXC
166
DELISTED
Asensus Surgical, Inc.
ASXC
| $95.7K | 0.06% |
300,000
-200,000
| -40% | -$51.6K |
|
167
Hyatt Hotels
H
$17.8B
| $87.6K | 0.06% |
672
-66
| -9% | -$7.49K |
|
168
Tapestry
TPR
$28.5B
| $85.1K | 0.06% |
2,313
-225
| -9% | -$6.93K |
|
169
Snowflake
SNOW
$95.1B
| $83.8K | 0.06% |
421
+167
| +66% | +$28.2K |
|
170
Coupang
CPNG
$29.5B
| $79.7K | 0.05% |
4,923
-490
| -9% | -$8.09K |
|
171
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$482M
| $77.8K | 0.05% |
+1,855
| New | +$73.4K |
|
172
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35B
| $77.8K | 0.05% |
+703
| New | +$73.2K |
|
173
iShares National Muni Bond ETF
MUB
$45.5B
| $76K | 0.05% |
701
+356
| +103% | +$37.2K |
|
174
Vertiv
VRT
$112B
| $75.9K | 0.05% |
+1,581
| New | +$67.3K |
|
175
TechnipFMC
FTI
$28.7B
| $75.7K | 0.05% |
+3,759
| New | +$77K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, AlphaCentric Advisors held 298 positions worth $149M, down 16% from $176M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
AlphaCentric Advisors withdrew a net $34.7M in Q4 2023, closing 82 positions and reducing 80 holdings. Its most notable exit was Neurocrine Biosciences, an estimated $3.38M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 62% a quarter earlier, followed by Real Estate and Financials.
Against the trend, AlphaCentric Advisors opened a new position in Abivax worth $2.86M.
- AlphaCentric Advisors's largest Q4 2023 buy was Abivax: 267,500 shares worth $2.86M.
- AlphaCentric Advisors added most to argenx in Q4 2023, an estimated $2.33M increase.
- AlphaCentric Advisors's biggest Q4 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $2.75M.
- AlphaCentric Advisors fully exited Neurocrine Biosciences in Q4 2023, selling an estimated $3.38M.
- AlphaCentric Advisors's ten largest holdings make up 25% of its $149M portfolio in Q4 2023.
- AlphaCentric Advisors opened 63 new positions and closed 82 in Q4 2023.
- AlphaCentric Advisors's portfolio value fell 16% quarter-over-quarter to $149M.
Based on AlphaCentric Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.